Skip to main content

Table 1 Epidemiological data about the 65 patients from Belgium and Luxembourg.

From: Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

Gender Female 31 (48.5%)
  Male 33 (51.5%)
  Unknown 1
Age Mean 42.84 years (range from 25 to 71)
  Median 42 years
Countries of origin West Africa 29 (63%)
     Ghana 8
     Ivory Coast 7
     Cape Verde Islands 5
     Guinea-Bissau 3
     Guinea 2
     Senegal 1
     Liberia 1
     Nigeria 1
     Burkina-Faso 1
  Europe 11 (24%)
     Belgium 6
     Portugal 5
  Central and Southern Africa 4 (8.5%)
     Democratic Republic Congo 3
     South-Africa 1
  Asia: Nepal 2 (4%)
  Not documented 19
Transmission Heterosexual 37 (86%)
  Homosexual (MSM) 2 (4.5%)
  Intra-venous drug use 2 (4.5%)
  Transfusion 2 (4.5%)
  Not documented 22
Year of infection Between 2002 and 2006 10 (33%)
  Between 1997 and 2001 7 (23%)
  Before 1997 13 (43%)
  Not documented 22
ARV use Treated 20 (31%)
     Exposed to NRTIs only 5
     Exposed to NRTIs and PIs 15
     Treated at the end of 2006 15
  Never been treated 45 (69%)
Subtype A 25 (83%)
  B 5 (17%)
  Not documented 35
  1. The percentages were calculated for patients with available data (collected until 2006-12-31). ARV: antiretroviral therapy
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us